CA
TTPH

Commerzbank Aktiengesellschaft’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-14,666
Closed -$2.19M – 1205
2015
Q3 		$2.19M Sell
14,666
-6,811
-32% -$5M 0.02% 422
2015
Q2 		$20.4M Buy
21,477
+3,054
+17% +$2.5M 0.11% 136
2015
Q1 		$13.5M Buy
18,423
+7,859
+74% +$5.9M 0.08% 183
2014
Q4 		$8.39M Sell
10,564
-974
-8% -$524K 0.05% 292
2014
Q3 		$4.6M Buy
+11,538
New +$3.09M 0.02% 511

Other funds holding TTPH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Commerzbank Aktiengesellschaft's TTPH Position: Q4 2015 in Review

Commerzbank Aktiengesellschaft sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2015, closing a stake of 14,666 shares — an estimated $2.19M sold.

Commerzbank Aktiengesellschaft first reported a position in TTPH in Q3 2014 and held it in 5 quarters. The position peaked at $20.4M in Q2 2015. 105 funds tracked by Wall St. Rank hold TTPH as of Q4 2015.

  • Commerzbank Aktiengesellschaft reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 14,666 Tetraphase Pharmaceuticals, Inc. shares in Q4 2015, an estimated $2.19M.
  • Commerzbank Aktiengesellschaft first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2014 and held it in 5 quarters.
  • Commerzbank Aktiengesellschaft's Tetraphase Pharmaceuticals, Inc. position peaked at $20.4M in Q2 2015.
  • 105 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2015.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q4 2015, filed 5 Feb 2016.